Evidence map›Paper›PMID 39430758›Full record

ArticleFrontiers in immunology2024

Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells.

Jelena Dimitrov, Maurizio Maddalena, Cristina Terlizzi, Giovanna G Altobelli, Sara Pellegrino, Tayyaba Mehmood, Viviana De Rosa, Francesca Iommelli, Silvana Del Vecchio

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Target neutrophil heterogeneity and plasticity in cancer.Journal of hematology & oncology · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. [Research Progress of Neutrophil Extracellular Traps in Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025
    Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jelena Dimitrov *Department of Advanced Biomedical Sciences, University "Federico II", Naples, Italy.
Maurizio Maddalena *Department of Advanced Biomedical Sciences, University "Federico II", Naples, Italy.
Cristina TerlizziInstitute of Biostructures and Bioimaging, National Research Council, Naples, Italy.
Giovanna G AltobelliDepartment of Advanced Biomedical Sciences, University "Federico II", Naples, Italy.
Sara PellegrinoDepartment of Advanced Biomedical Sciences, University "Federico II", Naples, Italy.
Tayyaba MehmoodDepartment of Advanced Biomedical Sciences, University "Federico II", Naples, Italy.
Viviana De RosaInstitute of Biostructures and Bioimaging, National Research Council, Naples, Italy.
Francesca IommelliInstitute of Biostructures and Bioimaging, National Research Council, Naples, Italy.
Silvana Del VecchioDepartment of Advanced Biomedical Sciences, University "Federico II", Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Neutrophil extracellular traps (NETs) are complex structures released by activated neutrophils that may modulate different steps of the metastatic cascade. The aim of our study was to investigate how NETs can modulate the adhesion properties of cancer cells and whether cell exposure to NETs can activate the epithelial-to-mesenchymal transition (EMT) program thus enhancing the migratory and invasive properties of tumor cells. Materials and methods: Different cancer cell lines were subjected to a solid-phase adhesion assay using NET-coated plates with or without the addition of antibodies against α5β1 or CCDC25 receptor. After 1-4 h of incubation, adherent cells were expressed as the percentage of total cell number. To test EMT occurrence, cells were treated with NETs for up to 48 h and then the levels of E-cadherin, vimentin, Snail, Slug, Zeb 1 and Twist 1 along with levels of Notch 1 and cleaved Notch 1 were determined by western blotting. Untreated and NET-treated cells were subjected to migration assays using 24-multiwell plates with transwell and FBS as chemoattractant. Results: Cancer cell adhesion to NET-coated plates varied between 30% and 92.7% and was significantly higher than that obtained in uncoated plates. The addition of antibodies against α5β1 or CCDC25 caused a strong reduction of cell adhesion to NETs. The prolonged exposure of EGFR-driven cancer cell lines to NETs caused the activation of the EMT program through the upregulation and cleavage of Notch 1 and was confirmed by the enhanced expression of EMT markers. The consequent loss of the epithelial phenotype induced a strong reduction of the expression of the oncogene driver. Cell migration was significantly enhanced in NET-treated cells as compared to untreated cells. Discussion: Our findings reveal the dynamic role of NETs that may provide a DNA and fibronectin rich environment for binding of many cancer cells at distant sites where the prolonged exposure to NETs triggers the EMT through the activation of Notch 1 signaling pathway with the subsequent enhancement of migratory and invasive properties of cancer cells. Furthermore, our findings provide an example of how an immune/inflammatory microenvironment may directly modulate the sensitivity of cancer cells to oncogene targeted agents.

Indexed as

Cell AdhesionEpithelial-Mesenchymal TransitionErbB ReceptorsExtracellular TrapsLung NeoplasmsReceptor, Notch1Cell Line, TumorCell MovementHumansNeutrophilsSignal TransductionEGFR protein, humanErbB ReceptorsNOTCH1 protein, humanReceptor, Notch1adhesionepithelial mesenchymal transitionmetastasismigrationneutrophil extracellular trapsNotch 1tumor microenvironment

Identifiers

PMID39430758
PMCPMC11487346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.